Fidelity Disrupt Medicin ETFFMEDETF
13F holders, Q2 2024 (June 30)8holders
1new positions
1sold out
$24.06avg. 13F price*
At the end of Q2 2024, 8 institutions reported holding Fidelity Disrupt Medicin ETF (FMED) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were FMR LLC ($17.6M), Wealth Enhancement Advisory Services, LLC ($12.5M) and Jane Street Group, LLC ($491K).
- Company
- Fidelity Disrupt Medicin ETF
- CUSIP
- 316092147
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $553 |
| Exits | 1 | $230 |
All 13F filers, Q1 2024 → Q2 2024: 23,753 shares bought and 28,786 shares sold, net −5,033 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| FMR LLC | 0.00% | Reduce -1.5% | 729,839 | $17.6M |
| Wealth Enhancement Advisory Services, LLC | 0.03% | Add +4.8% | 520,587 | $12.5M |
| Jane Street Group, LLC | 0.00% | Reduce -46.8% | 20,418 | $491K |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 162 | $4K |
| Central Pacific Bank - Trust Division | 0.00% | No change | 97 | $2K |
| Glen Eagle Advisors, LLC | 0.00% | No change | 90 | $2K |
| Dunhill Financial, LLC | 0.00% | No change | 36 | $1K |
| UBS Group AG | 0.00% | New | 23 | $553 |
"% of holder's portfolio" is FMED's weight in each manager's 13F, not the share of Fidelity Disrupt Medicin ETF the manager owns.